首页> 外文OA文献 >HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation

【2h】

HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation

机译：HLA匹配和HLA-Haploidentical同种异体CD19定向的嵌合抗原受体T细胞输注是在造血干细胞移植前复发或难治性B细胞急性淋巴细胞白血病的可行性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Xin Jin; Yaqing Cao; Luqiao Wang; Rui Sun; Lin Cheng; Xiaoyuan He; Xia Xiao; Yili Jiang; Qing Li; Huan Zhang; Wenyi Lu; Cuicui Lyu; Yanyu Jiang; Juanxia Meng; Mingfeng Zhao;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation [J] . Xin Jin, Yaqing Cao, Luqiao Wang, Leukemia . 2020,第3期

机译：HLA匹配和HLA-Haploidentical同种异体CD19定向的嵌合抗原受体T细胞输注是在造血干细胞移植前复发或难治性B细胞急性淋巴细胞白血病的可行性
2. Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why? [J] . Huiwen Jiang, Yu Hu, Heng Mei Biomarker Research . 2020,第1期

机译：嵌合抗原受体T细胞治疗后的共同异种造血干细胞移植术后/难治性B细胞急性淋巴细胞白血病：谁？什么时候？为什么？
3. Immunotherapy with Autologous Anti-CD19 Chimeric Antigen Receptor T Cells Followed By Allogeneic Hematopoietic Stem Cell Transplantation Has Remarkably Improved Leukemia-Free Survival in Refractory/Relapsed B-Cell Acute Lymphoblastic Leukemia [J] . Zhao Yan-Li, Wu Tong, Liu De-Yan, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：自体抗CD19嵌合抗原受体T细胞的免疫治疗，随后进行异基因造血干细胞移植，显着改善了难治性/复发性B细胞急性淋巴细胞白血病中的无白血病生存率。
4. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

机译：匹配的无关供体同种异体造血干细胞移植后急性白血病患者的遗传协会。
5. Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why? [O] . Huiwen Jiang, Yu Hu, Heng Mei 2020

机译：嵌合抗原受体T细胞治疗后的共同异种造血干细胞移植术后/难治性B细胞急性淋巴细胞白血病：谁？什么时候？为什么？
6. Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial [O] . Huiwen Jiang, Chenggong Li, Ping Yin, 2019

机译：抗CD19嵌合抗原受体改性T细胞治疗桥接对复发/难治性B细胞急性淋巴细胞白血病的同种异体造血干细胞移植：开放式务实临床试验

HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅